Hong Kong Aerospace & Defense Stock News

Market forces rained on the parade of NetDragon Websoft Holdings Limited ( HKG:777 ) shareholders today, when the...

Today is shaping up negative for Kingsoft Corporation Limited ( HKG:3888 ) shareholders, with the analysts delivering a...

One thing we could say about the analysts on West China Cement Limited ( HKG:2233 ) - they aren't optimistic, having...

It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...

One thing we could say about the covering analyst on Beijing Chunlizhengda Medical Instruments Co., Ltd. ( HKG:1858...

The latest analyst coverage could presage a bad day for China Datang Corporation Renewable Power Co., Limited...

Jiaxin International Resources Investment Limited ( HKG:3858 ) shareholders will have a reason to smile today, with the...

Earnings shift draws fresh attention to InnoCare Pharma InnoCare Pharma (SEHK:9969) has drawn fresh attention after reporting full year 2025 sales of CN¥2,374.91 million and net income of CN¥642.47 million, compared with a net loss a year earlier. See our latest analysis for InnoCare Pharma. The earnings swing has coincided with strong price momentum, with a 31.19% 1 month share price return and a 24.16% year to date share price return at HK$15.52. The 1 year total shareholder return of...

Fosun International (SEHK:656) has come under closer focus after reporting a larger net loss for 2025, withholding a dividend for the year, and outlining a higher dividend payout framework starting from the 2026 financial year. See our latest analysis for Fosun International. The recent dividend decision and larger 2025 net loss come after a mixed share price pattern, with a 19.5% 1 month share price return and a 9.91% 1 year total shareholder return contrasting with weaker multi year total...

Recent share performance and business snapshot Ascentage Pharma Group International (SEHK:6855) has drawn investor attention after recent share price moves, with returns of about 13% over the past week and 15% over the past month. The Suzhou based clinical stage biotech focuses on therapies for cancers, chronic hepatitis B and age related diseases in Mainland China. It generated HK$574.12 million in revenue and reported a net loss of HK$1,242.77 million. See our latest analysis for Ascentage...

Why Angelalign Technology’s latest earnings and dividends matter for investors Angelalign Technology (SEHK:6699) has drawn fresh attention after releasing full year 2025 earnings, alongside a proposed special dividend of HK$4.99 per share and affirming its regular annual payout. See our latest analysis for Angelalign Technology. Since these results and dividend announcements, the share price has gained momentum, with a 30 day share price return of 11.71%, a year to date share price return of...

Those following along with Shenzhou International Group Holdings Limited ( HKG:2313 ) will no doubt be intrigued by the...

The market seemed underwhelmed by last week's earnings announcement from Guangdong Kanghua Healthcare Group Co., Ltd...

The recent earnings posted by China Hongguang Holdings Limited ( HKG:8646 ) were solid, but the stock didn't move as...

Xtep International Holdings Limited ( HKG:1368 ) shareholders (or potential shareholders) will be happy to see that the...

Beijing Xunzhong Communication Technology Co., Ltd. ( HKG:2597 ) just released a solid earnings report, and the stock...

We wouldn't blame Great Wall Terroir Holdings Limited ( HKG:524 ) shareholders if they were a little worried about the...

One thing we could say about the analysts on Metallurgical Corporation of China Ltd. ( HKG:1618 ) - they aren't...

As global markets navigate the complexities of Middle East tensions and energy market volatility, Asian small-cap stocks present intriguing opportunities amid a backdrop of mixed economic signals. With key indices showing resilience and geopolitical uncertainties influencing investor sentiment, identifying promising small-cap companies requires a focus on those with robust fundamentals and strategic insider actions that align with current market dynamics.

The analysts covering C&D International Investment Group Limited ( HKG:1908 ) delivered a dose of negativity to...

The market was pleased with the recent earnings report from Chaoju Eye Care Holdings Limited ( HKG:2219 ), despite the...

FWD Group Holdings: recent performance snapshot FWD Group Holdings (SEHK:1828) has drawn investor attention after recent share price moves, with the stock showing mixed short term returns and a last close of HK$31.18 on the Hong Kong market. See our latest analysis for FWD Group Holdings. Recent trading has been choppy, with a 1 day share price return of 1.52% decline and a 7 day share price return of 2.63% gain, set against a 30 day share price return of 10.66% decline and a year to date...

Bank of China Limited reported its full-year 2025 results, with net interest income of CNY 440.71 billion and net income of CNY 243.02 billion, and the board recommended a 2025 final dividend of CNY 1.169 per 10 shares, subject to shareholder approval. The bank also confirmed Ms. Huang Xueling’s appointment as Executive Vice President in late March 2026, highlighting ongoing leadership renewal alongside a higher proposed cash return to shareholders. We’ll now examine how the higher proposed...

Why the latest results matter for dividend focused investors China Merchants Port Holdings (SEHK:144) has reported full year 2025 results with sales of HK$13,354 million and net income of HK$6,504 million, alongside a recommended lower final dividend of HK$0.489 per share. The board’s proposal compares with a final dividend of HK$0.636 per share for 2024. This may prompt investors to reassess how earnings quality, payout levels and long term income expectations line up for the stock after...